Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Real-World Analysis of Cytopenias after Chimeric Antigen Receptor T-Cell Therapy: A Comparison of BCMA and CD19 Based Outcomes

Tony Z. Zhuang, Manali Rupji, Pranav R. Santapuram, Michael Graiser, Jason T. Romancik, Jonathon B. Cohen

Blood (2022) 140 (Supplement 1): 12133–12134.

https://doi.org/10.1182/blood-2022-166196

Published: 2022

Journal Articles

Abatacept for the Prevention of Gvhd in Pediatric and Adult Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis

Sharmila Raghunandan, Lev Gorfinkel, Michael Graiser, Brandi Bratrude, Kayla Betz, Yvonne Suessmuth, Scott Gillespie, Adrianna Lynn Westbrook, Kirsten M. Williams, Michelle Schoettler, Amelia Langston, Leslie Kean, Muna Qayed, John T. Horan, Benjamin Watkins

Blood (2022) 140 (Supplement 1): 7653–7655.

https://doi.org/10.1182/blood-2022-163627

Published: 2022

Journal Articles

Evaluating Outcomes for Autologous Hematopoietic Cell Transplantation for Diffuse Large B-Cell Lymphoma in the CAR-T Era

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-142110

Published: 2020

Journal Articles

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Ani Gvajaia, MD, Amelia Langston, MD, Natia Esiashvil, MD, Michael Graiser, PhD, Kelly Valla, PharmD, Edmund K. Waller, PhDMD

Blood (2019) 134 (Supplement_1): 5657.

https://doi.org/10.1182/blood-2019-122467

Published: 2019

Journal Articles

Safety and Efficacy of Evomela™ in Myeloma Autotransplants

Kimberly Amelsberg, Nisha Joseph, MD, Amelia Langston, MD, Jonathan L Kaufman, MD, Craig C Hofmeister, MD MPH, Edmund K. Waller, MD, Michael Graiser, PhD, Robin Larocco, Leonard Heffner, MD, Madhav V Dhodapkar, MD, Sagar Lonial, MD, Ajay K Nooka, MD MPH

Blood (2018) 132 (Supplement 1): 3446.

https://doi.org/10.1182/blood-2018-99-119730

Published: 2018

Journal Articles

Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Blood (2018) 132 (Supplement 1): 2157.

https://doi.org/10.1182/blood-2018-99-118896

Published: 2018

Journal Articles

Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant — Obesity Associated with Inferior Outcomes

Andrew Ip, MD, Jeffrey M. Switchenko, PhD MS, Michael Graiser, Jean L. Koff, MD, Vikas A. Gupta, MD PhD, Ajay K. Nooka, MDMPH, Zaid Al-Kadhimi, MD, Mary Jo Lechowicz, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Edmund K. Waller, MD, Amelia Langston, MD, Christopher Flowers, MD, Jonathon B Cohen, MDMS

Blood (2017) 130 (Supplement 1): 5516.

https://doi.org/10.1182/blood.V130.Suppl_1.5516.5516

Published: 2017

Journal Articles

Prolonged Progression-Free Survival Is Possible in Patients with Diffuse Large B-Cell Lymphoma Receiving > 1 Salvage Therapies before Autologous Stem Cell Transplant

Abigail G Kettle, Jeffrey Switchenko, PhD, Oscar Calzada, BS, Anh Thuy Phan, MPH, Monique Farone, MPH, Michael Graiser, PhD, Christopher R. Flowers, MD, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 5825.

https://doi.org/10.1182/blood.V128.22.5825.5825

Published: 2016

Journal Articles

Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry

Eden Hailemichael, Highschool student, Jonathan L. Kaufman, MD, Christopher R. Flowers, MD, Edmund K. Waller, MD, PhD, Mary Jo Lechowicz, MD, Amelia Langston, MD, Michael Graiser, PhD, Lawrence H. Boise, PhD, Sagar Lonial, MD, Ajay K. Nooka, MD, MPH, FACP

Blood (2012) 120 (21): 2072.

https://doi.org/10.1182/blood.V120.21.2072.2072

Published: 2012

Journal Articles

Post-Transplant Platelet Recovery Kinetics and Its Association with Overall Survival in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Jie Li, Jillian Alyse Deppa, Zahir Ali, Michael Graiser, PhD, Amelia Langston, MD, Charise Gleason, Jessica Thomas, Edmund K Waller, MD PhD

Blood (2011) 118 (21): 2049.

https://doi.org/10.1182/blood.V118.21.2049.2049

Published: 2011

Journal Articles

Older Patients with Hodgkin Lymphoma (HL) Undergoing Autologous Stem Cell Transplantation for Relapsed/Refractory Disease Have Inferior Survival Compared to Younger Patients

Akshay Sharma, MD, Minghui Duan, MD, Michael Graiser, PhD, Hongzheng Zhang, MPH PhD, Amelia Langston, MD, Sagar Lonial, MD, Christopher R Flowers, MD, Ann Haight, MD, Edmund K Waller, MD PhD

Blood (2011) 118 (21): 4521.

https://doi.org/10.1182/blood.V118.21.4521.4521

Published: 2011

Journal Articles

Cost-Effectiveness Analysis of a “Just-In-Time” Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant

Jie Li, Ellie Hamilton, Louette Vaughn, Michael Graiser, Heather Renfroe, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Christopher R Flowers, MD, MS, Mary Jo Lechowicz, MD, Amelia Langston, MD, Darlene Anderson, Edmund Waller, MD, PhD

Blood (2010) 116 (21): 2246.

https://doi.org/10.1182/blood.V116.21.2246.2246

Published: 2010

Journal Articles

Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Hongzheng Zhang, Michael Graiser, Donald Hutcherson, M. Olufemi Dada, Stephanie McMillan, BSN, RN, OCN, Ali Zahir, Christopher R Flowers, MD, MS, Edmund Waller

Blood (2010) 116 (21): 1359.

https://doi.org/10.1182/blood.V116.21.1359.1359

Published: 2010

NARROW

Real-World Analysis of Cytopenias after Chimeric Antigen Receptor T-Cell Therapy: A Comparison of BCMA and CD19 Based Outcomes

Abatacept for the Prevention of Gvhd in Pediatric and Adult Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis

Evaluating Outcomes for Autologous Hematopoietic Cell Transplantation for Diffuse Large B-Cell Lymphoma in the CAR-T Era

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Safety and Efficacy of Evomela™ in Myeloma Autotransplants

Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant — Obesity Associated with Inferior Outcomes

Prolonged Progression-Free Survival Is Possible in Patients with Diffuse Large B-Cell Lymphoma Receiving > 1 Salvage Therapies before Autologous Stem Cell Transplant

Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry

Post-Transplant Platelet Recovery Kinetics and Its Association with Overall Survival in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Older Patients with Hodgkin Lymphoma (HL) Undergoing Autologous Stem Cell Transplantation for Relapsed/Refractory Disease Have Inferior Survival Compared to Younger Patients

Cost-Effectiveness Analysis of a “Just-In-Time” Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant

Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only